Likewise, Metformin can attenuate hepatoma cell proliferation by decreasing glycolytic flux via the HIF-1α/PFKFB3/PFK1 pathway (157) and overcome MR-induced resistance of skin carcinoma to photodynamic therapy (158). Here, PFKFB3 is linked to skin carcinoma.